M. Viguier

In vivo T helper cell response to retro-inverso peptidomimetics

Cécile Meźière, M. Viguier, Hélène Dumortier et al. · The Journal of Immunology · 1997 · 38 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Passive but not active CD8+ T cell-based immunotherapy interferes with liver tumor progression in a transgenic mouse model.

R Romieu, Myriam Baratin, Michèle Kayibanda et al. · PubMed · 1998 · 36 citations

Life Sciences, Immunology, Oncology +17

Specific antigen targeting to surface IgE and IgG on mouse bone marrow‐derived mast cells enhances efficiency of antigen presentation

Christine Tkaczyk, M. Viguier, Yvan Boutin et al. · Immunology · 1998 · 18 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Does preventive vaccination with engineered tumor cells work in cancer-prone transgenic mice?

Alain Morel, de La Coste A, Nadine Fernandez et al. · PubMed · 1998 · 12 citations

Medicine, Immunology, Oncology +16

The invariant chain forms complexes with class II major histocompatibility complex molecules and antigenic peptides "in vivo".

M. Viguier, Klaus Dornmair, Brian R. Clark et al. · Proceedings of the National Academy of Sciences · 1990 · 11 citations

Life Sciences, Biochemistry, Immunology +15